Efficacy, Pharmacokinetics, Safety, and Tolerability of IGSC 20% in Subjects With Primary Immunodeficiency
Clinical trial NCT02806986 · COMPLETED
Trial details
- NCT number
- NCT02806986
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2019-05-15
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.